NCT04826211View on ClinicalTrials.gov

Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI

NACompletedINTERVENTIONAL

Enrollment

109

Participants

Timeline

Start Date

November 4, 2019

Primary Completion Date

April 30, 2024

Study Completion Date

December 31, 2024

Conditions

Breast Cancer FemaleNode-positive Breast CancerSentinel Lymph Node

Interventions

DIAGNOSTIC_TEST

PET/MRI

All included patients will undergo PET/MRI both prior to PST and prior to surgery. In order to analyze results the population will be divided into two groups: women with positive axillary lymph nodes after PST (Group 1) and women with negative axillary lymph nodes after PST (Group 2).

Trial Locations (1)

20132

Ospedale San Raffaele, Milan

All Listed Sponsors

collaborator

"Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy"

OTHER_GOV

lead

IRCCS San Raffaele

OTHER

NCT04826211 - Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI | Biotech Hunter | Biotech Hunter